Portola jumps on FDA approval of Andexxa

Portola Pharmaceuticals Inc. (NASDAQ:PTLA) gained $8.66 (26%) to $42.44 on Friday after FDA granted accelerated approval to a resubmitted BLA for its Andexxa andexanet alfa. Portola announced the approval after market close on Thursday.

The agency

Read the full 351 word article

User Sign In